| Residential College | false |
| Status | 已發表Published |
| The global patent landscape of HER2-targeted biologics | |
| Li, Qingjian1; Xu, Jiaqi2; Sun, Qianshu2; Zhang, Zebang1; Hu, Yuanjia2,3; Yao, Herui1 | |
| 2023-06-01 | |
| DOI | 10.1038/s41587-023-01814-8 |
| Language | 英語English |
| URL | View the original |
| Scopus ID | 2-s2.0-85161951367 |
| Fulltext Access | |
| Citation statistics | |
| Document Type | Other |
| Collection | University of Macau |
| Affiliation | 1.Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medical Oncology, Breast Tumor Centre, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China 2.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao 3.Department of Public Health and Medicinal Administration, Faculty of Health Sciences, University of Macau, Taipa, Macao |
| Recommended Citation GB/T 7714 | Li, Qingjian,Xu, Jiaqi,Sun, Qianshu,et al. The global patent landscape of HER2-targeted biologics. 2023-06-01. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment